Gilead Sciences, Inc. (GILD) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $123.76 -1.35%
Revenue Growth %: +4.4%
Financial Fact:
Total costs and expenses: 3.1B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +4.4%
Financial Fact:
Total costs and expenses: 3.1B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q1 EPS of $0.91, $0.03 worse than the analyst estimate of $0.94. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.2 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
